BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 26, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 9, 2006
View Archived Issues
Merimepodib does not enhance ribavirin effects in hepatitis C
Read More
Obatoclax mesylate sensitizes cholangiocarcinoma cells to apoptosis
Read More
Novartis presents Q3 report
Read More
Raptor inlicenses Mesd reagents for treatment of cancer and osteoporosis
Read More
Ambit and Cephalon form kinase inhibitor collaboration
Read More
Novel hyaluronic acid binding peptide shows potential to prevent and treat wound infections
Read More
Parthenolide analogue LC-1 shows promising antitumor activity in preclinical studies
Read More
Dosing begins in phase IIb study of Tovaxin in MS
Read More
Trovax begins phase III trial in renal cancer
Read More
CYT009-GhrQb shows no effect on weight loss in obesity study
Read More
Maxy-alpha begins phase Ia study
Read More
Orphan drug designation for MORAb-009 in pancreatic cancer
Read More
Samaritan submits IND for Alzheimer's candidate caprospinol
Read More
Archimedes Pharma acquires Link Holdings
Read More
European orphan drug designation for Neuradiab in GBM
Read More
New crystalline form of ANA-975 studied in additional preclinical toxicology study
Read More
Avalon begins drug discovery program for survivin pathway
Read More
Lux licenses ciclosporin-eluting silicone matrix ocular implant from NIH
Read More
Melior signs research collaboration with Merck & Co.
Read More
IPI-504 shows promising biological activity in GIST
Read More
Mepact filed in E.U. for osteosarcoma
Read More
Avonex launched in Japan
Read More
Cyclacel and Roche report on the antitumor potential of new selective CDK inhibitors
Read More
Final phase I results and preclinical data on YM-155
Read More
Efficacy of DEBIO-025 in HIV/HCV co-infected patients
Read More
Novel 5-HT6 antagonist from Suven shows antiobesity properties in animal models
Read More
Recent Elan, Xenon and Gruenenthal patents disclose novel analgesic agents
Read More
Recent Tibotec and Trimeris patents report novel agents for HIV infection
Read More
Novel agents for cardiovascular disorders disclosed in recent patents
Read More
